2011Unpublished venueRequires access

Influence of losartan on plasma level of brain natriuretic peptide in patients with hypertension complicated left ventricular hypertrophy

Jianhong Tao

Open publisher page 0 citations

Abstract

Objective:To study effects of losartan on level of brain natriuretic peptide(BNP) in patients with essential hypertension(EH) complicated left ventricular hypertrophy(LVH) and its significance.Methods:The 100 EH patients with normal left ventricular ejection fraction(LVEF) were selected,and there were 58 cases complicated with LVH and 42 pure EH cases.Another 50 healthy subjects were regard as healthy control group.Plasma levels of BNP were compared among the three groups.EH+LVH group were given losartan for six months,the changes of BNP level and left ventricular mass index(LVMI) were compared before and after treatment.Results: ① Plasma level of BNP of EH + LVH group was significantly higher than those of pure EH group and healthy control group [(62.21±9.70) pg/ml vs.(39.35±10.57) pg/ml vs.(13.89±5.34) pg/ml,P0.01];② Concentration of BNP was positively correlated with LVMI(r=0.44,P0.05);③ Compared with before treatment,there were significant decrease in plasma level of BNP [(62.21±9.70) pg/ml vs.(38.78±7.94) pg/ml] and LVMI [(128.71±12.64) g/m2 vs.(107.36±11.32) g/m2] in EH + LVH group after six-month treatment with losartan,P0.01 both.Conclusion:Losartan can significantly decrease level of brain natriuretic peptide and reverse left ventricular hypertrophy in patients with hypertension complicated left ventricular hypertrophy.

About this research paper

What this paper is about

Objective:To study effects of losartan on level of brain natriuretic peptide(BNP) in patients with essential hypertension(EH) complicated left ventricular hypertrophy(LVH) and its significance.Methods:The 100 EH patients with normal left ventricular ejection fraction(LVEF) were selected,and there were 58 cases complicated with LVH and 42 pure EH cases.Another 50 healthy subjects were regard as healthy control group.Plasma levels of BNP were compared among the three groups.EH+LVH group were given losartan for six months,the changes of BNP level and left ventricular mass index(LVMI) were compared before and after treatment.Results: ① Plasma level of BNP of EH + LVH group was significantly higher than those of pure EH group and healthy control group [(62.21±9.70) pg/ml vs.(39.35±10.57) pg/ml vs.(13.89±5.34) pg/ml,P0.01];② Concentration of BNP was positively correlated with LVMI(r=0.44,P0.05);③ Compared with before treatment,there were significant decrease in plasma level of BNP [(62.21±9.70) pg/ml vs.(38.78±7.94) pg/ml] and LVMI [(128.71±12.64) g/m2 vs.(107.36±11.32) g/m2] in EH + LVH group after six-month treatment with losartan,P0.01 both.Conclusion:Losartan can significantly decrease level of brain natriuretic peptide and reverse left ventricular hypertrophy in patients with hypertension complicated left ventricular hypertrophy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study effects of losartan on level of brain natriuretic peptide(BNP) in patients with essential hypertension(EH) complicated left ventricular hypertrophy(LVH) and its significance.Methods:The 100 EH patients with normal left ventricular ejection fraction(LVEF) were selected,and there were 58 cases complicated with LVH and 42 pure EH cases.Another 50 healthy subjects were regard as healthy control group.Plasma levels of BNP were compared among the three groups.EH+LVH group were given losartan for six months,the changes of BNP level and left ventricular mass index(LVMI) were compared before and after treatment.Results: ① Plasma level of BNP of EH + LVH group was significantly higher than those of pure EH group and healthy control group [(62.21±9.70) pg/ml vs.(39.35±10.57) pg/ml vs.(13.89±5.34) pg/ml,P0.01];② Concentration of BNP was positively correlated with LVMI(r=0.44,P0.05);③ Compared with before treatment,there were significant decrease in plasma level of BNP [(62.21±9.70) pg/ml vs.(38.78±7.94) pg/ml] and LVMI [(128.71±12.64) g/m2 vs.(107.36±11.32) g/m2] in EH + LVH group after six-month treatment with losartan,P0.01 both.Conclusion:Losartan can significantly decrease level of brain natriuretic peptide and reverse left ventricular hypertrophy in patients with hypertension complicated left ventricular hypertrophy.

Key concepts: Medicine, Losartan, Left ventricular hypertrophy, Internal medicine, Brain natriuretic peptide, Cardiology, Ejection fraction, Essential hypertension

Related papers

Back to paper searchBrowse research topicsOriginal source
Influence of losartan on plasma level of brain natriuretic peptide in patients with hypertension complicated left ventricular hypertrophy — Research Paper | ScholarLens